The mode of action of 5-hydroxytryptamine.
D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D002082:Butylamines / Q000494:pharmacology; D004175:Diptera; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D007210:Indoleacetic Acids / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D008744:Methylamines / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011955:Receptors, Drug; D012463:Saliva / Q000378:metabolism; D012469:Salivary Glands / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship
D000605:Amino Alcohols; D002082:Butylamines; D005021:Ethylamines; D005029:Ethylenediamines; D007210:Indoleacetic Acids; D007211:Indoles; D008744:Methylamines; D010627:Phenethylamines; D011437:Propylamines; D000644:Quaternary Ammonium Compounds; D011955:Receptors, Drug; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine